640.3K XNAS Volume
XNAS 24 Mar, 2025 1:08 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Michael A. Alrutz | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 13 Feb 2025 | 1,600 | 213,596 (0%) | 0% | 4.5 | 7,226 | Common Stock |
| Michael T. Andriole | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 13 Feb 2025 | 7,370 | 609,603 (0%) | 0% | 4.5 | 33,282 | Common Stock |
| David Jakeman | VP OF FINANCE AND ACCOUNTING | Sale of securities on an exchange or to another person at price $ 4.53 per share. | 13 Feb 2025 | 300 | 148,987 (0%) | 0% | 4.5 | 1,360 | Common Stock |
| Allen S. Melemed | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.50 per share. | 13 Feb 2025 | 3,065 | 152,875 (0%) | 0% | 4.5 | 13,799 | Common Stock |
| Michelle LaSpaluto | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 13 Feb 2025 | 2,260 | 172,977 (0%) | 0% | 4.5 | 10,196 | Common Stock |
| Michael T. Andriole | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 4.10 per share. | 30 Jan 2025 | 2,350 | 616,973 (0%) | 0% | 4.1 | 9,636 | Common Stock |
| David Jakeman | VP OF FINANCE AND ACCOUNTING | Sale of securities on an exchange or to another person at price $ 4.10 per share. | 30 Jan 2025 | 2,800 | 149,287 (0%) | 0% | 4.1 | 11,470 | Common Stock |
| Michelle LaSpaluto | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.11 per share. | 30 Jan 2025 | 1,015 | 175,237 (0%) | 0% | 4.1 | 4,172 | Common Stock |
| Michael A. Alrutz | SVP AND GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 41,667 | 215,196 (0%) | 0% | 0 | Common Stock | |
| Michael A. Alrutz | SVP AND GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Michael T. Andriole | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 150,000 | 619,323 (1%) | 0% | 0 | Common Stock | |
| Michael T. Andriole | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Thomas J. Riga | COO and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 54,275 | 57,501 (0%) | 0% | 0 | Common Stock | |
| Thomas J. Riga | COO and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 325,000 | 325,000 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | VP OF FINANCE AND ACCOUNTING | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | VP OF FINANCE AND ACCOUNTING | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 10,855 | 152,087 (0%) | 0% | 0 | Common Stock | |
| Allen S. Melemed | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 45,925 | 155,940 (0%) | 0% | 0 | Common Stock | |
| Allen S. Melemed | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Michelle LaSpaluto | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 41,667 | 176,252 (0%) | 0% | 0 | Common Stock | |
| Michelle LaSpaluto | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Fred A. Middleton | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Oct 2024 | 60,000 | 40,000 (0%) | 0% | 0 | Common Stock | |
| Michael T. Andriole | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 08 Aug 2024 | 1,285 | 462,453 (0%) | 0% | 0.8 | 1,065 | Common Stock |
| Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Fred A. Middleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Marc D. Kozin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Pratik S. Multani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Meyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Lisa Lynn Decker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Marc D. Kozin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Michelle LaSpaluto | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 14 Feb 2024 | 1,940 | 110,999 (0%) | 0% | 1.0 | 2,023 | Common Stock |
| Andriole Michael T. | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 14 Feb 2024 | 1,744 | 447,021 (0%) | 0% | 1.0 | 1,809 | Common Stock |
| David Jakeman | VP OF FINANCE AND ACCOUNTING | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 14 Feb 2024 | 2,660 | 141,232 (0%) | 0% | 1.0 | 2,777 | Common Stock |
| T. Michael Andriole | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 502,500 | 502,500 | - | - | Stock Option (Right to Buy) | |
| Melemed S. Allen | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 168,750 | 168,750 | - | - | Stock Option (Right to Buy) | |
| Jakeman David | VP OF FINANCE AND ACCOUNTING | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 10,750 | 143,892 (0%) | 0% | 0 | Common Stock | |
| Alrutz A. Michael | SVP AND GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 131,250 | 131,250 | - | - | Stock Option (Right to Buy) | |
| Andriole Michael T. | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 83,750 | 448,765 (0%) | 0% | 0 | Common Stock | |
| David Jakeman | VP OF FINANCE AND ACCOUNTING | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 64,500 | 64,500 | - | - | Stock Option (Right to Buy) | |
| Michelle LaSpaluto | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 25,000 | 112,939 (0%) | 0% | 0 | Common Stock | |
| Allen Melemed S. | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 28,125 | 86,430 (0%) | 0% | 0 | Common Stock | |
| LaSpaluto Michelle | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Michael Alrutz A. | SVP AND GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 21,875 | 168,098 (0%) | 0% | 0 | Common Stock | |
| T. Michael Andriole | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Dec 2023 | 17,000 | 365,015 (0%) | 0% | 0 | Common Stock | |
| Michelle LaSpaluto | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 17,000 | 17,000 | - | - | Employee Stock Option (Right to Buy) | |
| Michael T. Andriole | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.19 per share. | 01 Aug 2023 | 25,000 | 382,015 (0%) | 0% | 1.2 | 29,750 | Common Stock |
| Michael T. Andriole | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Fred A. Middleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Pratik S. Multani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Meyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Michael T. Andriole | Chief Business Officer and CFO | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 18 May 2023 | 51,700 | 357,015 (0%) | 0% | 1.1 | 59,150 | Common Stock |
| Michael Sherman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.12 per share. | 12 May 2023 | 75,015 | 87,000 (0%) | 0% | 1.1 | 84,122 | Common Stock |
| Michael Sherman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 12 May 2023 | 11,985 | 11,985 (0%) | 0% | 1.1 | 13,530 | Common Stock |
| Martha J. Demski | Director | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 10 May 2023 | 18,000 | 72,055 (0%) | 0% | 1.1 | 19,980 | Common Stock |
| Robert J. Meyer | Director | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 08 May 2023 | 8,750 | 35,150 (0%) | 0% | 1.1 | 9,975 | Common Stock |
| Fred A. Middleton | Director | Purchase of securities on an exchange or from another person at price $ 1.21 per share. | 28 Mar 2023 | 20,000 | 60,000 (0%) | 0% | 1.2 | 24,152 | Common Stock |
| David Jakeman | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 26 Jan 2023 | 3,230 | 136,752 (0%) | 0% | 1.8 | 5,686 | Common Stock |
| Michael A. Alrutz | Principal Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 21,450 | 142,015 (0%) | 0% | 0 | Common Stock | |
| Michael A. Alrutz | Principal Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 128,550 | 128,550 | - | - | Stock Option (Right to Buy) | |
| Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 557,050 | 557,050 | - | - | Stock Option (Right to Buy) | |
| Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 92,950 | 222,995 (0%) | 0% | 0 | Common Stock | |
| Michael T. Andriole | Chief Business Officer and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 192,825 | 192,825 | - | - | Stock Option (Right to Buy) | |
| Michael T. Andriole | Chief Business Officer and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 32,175 | 294,899 (0%) | 0% | 0 | Common Stock | |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 24,950 | 24,950 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 12,450 | 139,982 (0%) | 0% | 0 | Common Stock | |
| Allen S. Melemed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 154,260 | 154,260 | - | - | Stock Option (Right to Buy) | |
| Allen S. Melemed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 25,740 | 47,887 (0%) | 0% | 0 | Common Stock | |
| Fred A. Middleton | Director | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 29 Sep 2022 | 20,000 | 40,000 (0%) | 0% | 1.9 | 37,176 | Common Stock |
| David Jakeman | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.86 per share. | 29 Sep 2022 | 4,400 | 127,532 (0%) | 0% | 1.9 | 8,185 | Common Stock |
| Michael T. Andriole | Chief Business Officer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2022 | 50,000 | 450,000 | - | - | Employee Stock Option (Right to Buy) | |
| Michael T. Andriole | Chief Business Officer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.09 per share. | 25 Aug 2022 | 50,000 | 262,724 (0%) | 0% | 2.1 | 104,500 | Common Stock |
| Michael Sherman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.09 per share. | 25 Jul 2022 | 100,000 | 125,364 (0%) | 0% | 2.1 | 209,000 | Common Stock |
| Michael Sherman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2022 | 100,000 | 1,150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Fred A. Middleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Pratik S. Multani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Meyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Fred A. Middleton | Director | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 19 May 2022 | 20,000 | 20,000 (0%) | 0% | 2.0 | 40,738 | Common Stock |
| Robert J. Meyer | Director | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 19 May 2022 | 1,419 | 26,400 (0%) | 0% | 2.1 | 2,909 | Common Stock |
| Robert J. Meyer | Director | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 19 May 2022 | 9,981 | 24,981 (0%) | 0% | 2.1 | 20,561 | Common Stock |
| Martha J. Demski | Director | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 17 May 2022 | 10,000 | 54,055 (0%) | 0% | 1.6 | 16,100 | Common Stock |
| Michael T. Andriole | Chief Business Officer and CFO | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 17 May 2022 | 15,000 | 212,724 (0%) | 0% | 1.7 | 25,635 | Common Stock |
| David Jakeman | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.56 per share. | 04 Feb 2022 | 3,300 | 117,666 (0%) | 0% | 5.6 | 18,355 | Common Stock |
| Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 875,000 | 875,000 | - | - | Stock Option (Right to Buy) | |
| Michael T. Andriole | Chief Business Officer and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 29,900 | 29,900 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 14,900 | 120,966 (0%) | 0% | 0 | Common Stock | |
| Allen S. Melemed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.19 per share. | 30 Sep 2021 | 4,590 | 106,066 (0%) | 0% | 6.2 | 28,412 | Common Stock |
| Fred A. Middleton | Director | Purchase of securities on an exchange or from another person at price $ 7.78 per share. | 25 Jun 2021 | 3,050 | 200,573 (0%) | 0% | 7.8 | 23,729 | Common Stock |
| Fred A. Middleton | Director | Purchase of securities on an exchange or from another person at price $ 7.83 per share. | 25 Jun 2021 | 6,950 | 207,523 (0%) | 0% | 7.8 | 54,419 | Common Stock |
| Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Fred A. Middleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Pratik S. Multani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Meyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.35 per share. | 05 Apr 2021 | 5,250 | 103,989 (0%) | 0% | 2.4 | 12,338 | Common Stock |
| David Jakeman | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 5,250 | 0 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 9.68 per share. | 05 Apr 2021 | 1,284 | 102,705 (0%) | 0% | 9.7 | 12,427 | Common Stock |
| Robert J. Meyer | Director | Purchase of securities on an exchange or from another person at price $ 9.80 per share. | 01 Mar 2021 | 1,500 | 15,000 (0%) | 0% | 9.8 | 14,700 | Common Stock |
| David Jakeman | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 28 Jan 2021 | 3,211 | 96,906 (0%) | 0% | 8.6 | 27,650 | Common Stock |
| Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| Michael T. Andriole | Chief Business Officer and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 15,000 | 100,117 (0%) | 0% | 0 | Common Stock | |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Allen S. Melemed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 1,500 | 1,500 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2020 | 7,042 | 0 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Nov 2020 | 7,042 | 44,055 (0%) | 0% | 0 | Common Stock | |
| Martha J. Demski | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Nov 2020 | 7,042 | 0 (0%) | 0% | 0 | Common Stock | |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.35 per share. | 17 Nov 2020 | 7,042 | 7,042 (0%) | 0% | 2.4 | 16,549 | Common Stock |
| David Jakeman | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.48 per share. | 02 Oct 2020 | 4,270 | 85,117 (0%) | 0% | 2.5 | 10,590 | Common Stock |
| Robert J. Meyer | Director | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 19 Aug 2020 | 3,500 | 13,500 (0%) | 0% | 2.9 | 10,220 | Common Stock |
| Martha J. Demski | Director | Sale of securities on an exchange or to another person at price $ 3.25 per share. | 10 Aug 2020 | 1,584 | 0 (0%) | 0% | 3.3 | 5,148 | Common Stock |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2020 | 1,584 | 0 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. | 10 Aug 2020 | 1,584 | 1,584 (0%) | 0% | 3.2 | 5,005 | Common Stock |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 2,500 | 1,584 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 2,500 | 4,084 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Sale of securities on an exchange or to another person at price $ 3.25 per share. | 06 Aug 2020 | 2,500 | 0 (0%) | 0% | 3.3 | 8,125 | Common Stock |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. | 06 Aug 2020 | 2,500 | 2,500 (0%) | 0% | 3.2 | 7,900 | Common Stock |
| Martha J. Demski | Director | Sale of securities on an exchange or to another person at price $ 3.29 per share. | 06 Aug 2020 | 2,500 | 0 (0%) | 0% | 3.3 | 8,224 | Common Stock |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. | 06 Aug 2020 | 2,500 | 2,500 (0%) | 0% | 3.2 | 7,900 | Common Stock |
| Martha J. Demski | Director | Sale of securities on an exchange or to another person at price $ 3.25 per share. | 04 Aug 2020 | 5,000 | 0 (0%) | 0% | 3.3 | 16,250 | Common Stock |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. | 04 Aug 2020 | 5,000 | 5,000 (0%) | 0% | 3.2 | 15,800 | Common Stock |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2020 | 2,500 | 6,584 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2020 | 5,000 | 9,084 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Sale of securities on an exchange or to another person at price $ 3.27 per share. | 04 Aug 2020 | 2,500 | 0 (0%) | 0% | 3.3 | 8,187 | Common Stock |
| Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. | 04 Aug 2020 | 2,500 | 2,500 (0%) | 0% | 3.2 | 7,900 | Common Stock |
| Allen S. Melemed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 400,000 | 400,000 | - | - | Employee Stock Option (Right to Buy) | |
| Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Fred A. Middleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Pratik S. Multani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Meyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Edward F. Greissing | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Michael T. Andriole | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.43 per share. | 16 Mar 2020 | 33,300 | 149,729 (0%) | 0% | 1.4 | 47,522 | Common Stock |
| Fred A. Middleton | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 12 Mar 2020 | 50,000 | 197,523 (0%) | 0% | 1.4 | 69,900 | Common Stock |
| Michael Sherman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.45 per share. | 12 Mar 2020 | 72,995 | 102,995 (0%) | 0% | 1.4 | 105,653 | Common Stock |
| Pratik S. Multani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2020 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.68 per share. | 07 Feb 2020 | 8,805 | 260,066 (0%) | 0% | 1.7 | 14,830 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.70 per share. | 07 Feb 2020 | 2,550 | 268,871 (0%) | 0% | 1.7 | 4,335 | Common Stock |
| David Jakeman | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.70 per share. | 07 Feb 2020 | 2,290 | 87,876 (0%) | 0% | 1.7 | 3,893 | Common Stock |
| Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2020 | 632,500 | 632,500 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2020 | 192,500 | 192,500 | - | - | Stock Option (Right to Buy) | |
| Michael T. Andriole | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2020 | 192,500 | 192,500 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2020 | 14,160 | 90,166 (0%) | 0% | 0 | Common Stock | |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2020 | 28,320 | 28,320 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.15 per share. | 07 Jan 2020 | 30,680 | 271,421 (0%) | 0% | 2.2 | 66,045 | Common Stock |
| Fred A. Middleton | None | Purchase of securities on an exchange or from another person at price $ 1.82 per share. | 11 Nov 2019 | 30,000 | 147,523 (0%) | 0% | 1.8 | 54,567 | Common Stock |
| Fred A. Middleton | None | Purchase of securities on an exchange or from another person at price $ 1.66 per share. | 11 Nov 2019 | 20,000 | 117,523 (0%) | 0% | 1.7 | 33,190 | Common Stock |
| Robert J. Meyer | None | Purchase of securities on an exchange or from another person at price $ 1.58 per share. | 06 Nov 2019 | 10,000 | 10,000 (0%) | 0% | 1.6 | 15,797 | Common Stock |
| Michael T. Andriole | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.56 per share. | 06 Nov 2019 | 100,000 | 100,000 (0%) | 0% | 1.6 | 156,000 | Common Stock |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2019 | 56,000 | 76,006 (0%) | 0% | 0 | Common Stock | |
| William Garrett Nichols | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.49 per share. | 25 Jul 2019 | 7,625 | 300,056 (0%) | 0% | 3.5 | 26,634 | Common Stock |
| Patrick C. Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Ronald C. Renaud | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Fred A. Middleton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Meyer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Edward F. Greissing | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| David Jakeman | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 10,000 | 10,000 | - | - | Employee Stock Option (Right to Buy) | |
| Martha J. Demski | None | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 28 May 2019 | 18,000 | 37,013 (0%) | 0% | 3.6 | 64,800 | Common Stock |
| Timothy W. Trost | SVP, CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.44 per share. | 22 May 2019 | 3,795 | 217,088 (0%) | 0% | 3.4 | 13,066 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 21 May 2019 | 4,695 | 307,681 (0%) | 0% | 3.5 | 16,270 | Common Stock |
| Michael Sherman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.48 per share. | 20 May 2019 | 30,000 | 30,000 (0%) | 0% | 3.5 | 104,316 | Common Stock |
| Fred A. Middleton | None | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 10 May 2019 | 30,000 | 97,523 (0%) | 0% | 2.9 | 87,678 | Common Stock |
| Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2019 | 1,250,000 | 1,250,000 | - | - | Employee Stock Option (Right to Buy) | |
| Michael T. Andriole | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2019 | 500,000 | 500,000 | - | - | Employee Stock Option (Right to Buy) | |
| Michael A. Alrutz | Principal Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 100,000 | 156,645 (0%) | 0% | 0 | Common Stock | |
| Timothy W. Trost | SVP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 100,000 | 214,530 (0%) | 0% | 0 | Common Stock | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 100,000 | 312,376 (0%) | 0% | 0 | Common Stock | |
| Timothy W. Trost | SVP, CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.20 per share. | 29 Jan 2019 | 2,588 | 114,530 (0%) | 0% | 2.2 | 5,694 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.20 per share. | 29 Jan 2019 | 3,095 | 212,376 (0%) | 0% | 2.2 | 6,821 | Common Stock |
| M. Michelle Berrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | SVP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 176,000 | 176,000 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 125,000 | 215,471 (0%) | 0% | 0 | Common Stock | |
| Patrick C. Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Ronald C. Renaud | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Fred A. Middleton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Meyer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Edward F. Greissing | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.50 per share. | 12 Jun 2018 | 10,000 | 99,685 (0%) | 0% | 4.5 | 45,015 | Common Stock |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 4.80 per share. | 17 May 2018 | 30,000 | 123,167 (0%) | 0% | 4.8 | 143,931 | Common Stock |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 4.81 per share. | 17 May 2018 | 15,000 | 108,167 (0%) | 0% | 4.8 | 72,143 | Common Stock |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 4.79 per share. | 16 May 2018 | 30,000 | 153,167 (0%) | 0% | 4.8 | 143,808 | Common Stock |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 4.69 per share. | 15 May 2018 | 30,000 | 183,167 (0%) | 0% | 4.7 | 140,808 | Common Stock |
| Linda M. Richardson | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.66 per share. | 14 May 2018 | 4,545 | 54,161 (0%) | 0% | 4.7 | 21,199 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.66 per share. | 14 May 2018 | 5,680 | 90,471 (0%) | 0% | 4.7 | 26,490 | Common Stock |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 4.57 per share. | 11 May 2018 | 7,143 | 258,577 (0%) | 0% | 4.6 | 32,614 | Common Stock |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 4.63 per share. | 11 May 2018 | 22,857 | 235,720 (0%) | 0% | 4.6 | 105,766 | Common Stock |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 4.67 per share. | 11 May 2018 | 22,553 | 213,167 (0%) | 0% | 4.7 | 105,232 | Common Stock |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 4.60 per share. | 10 May 2018 | 2,815 | 265,720 (0%) | 0% | 4.6 | 12,949 | Common Stock |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2018 | 4,225 | 0 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share. | 09 May 2018 | 4,225 | 19,013 (0%) | 0% | 1.6 | 6,633 | Common Stock |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.26 per share. | 08 May 2018 | 11,250 | 325,256 (0%) | 0% | 4.3 | 47,925 | Common Stock |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2018 | 11,250 | 15,161 | - | - | Stock Option (Right to Buy) | |
| Fred A. Middleton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2018 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Meyer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2018 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| Edward F. Greissing | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2018 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.26 per share. | 06 Mar 2018 | 10,071 | 311,336 (0%) | 0% | 4.3 | 42,902 | Common Stock |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2018 | 10,071 | 26,411 | - | - | Stock Option (Right to Buy) | |
| Linda M. Richardson | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.67 per share. | 02 Feb 2018 | 2,290 | 58,706 (0%) | 0% | 4.7 | 10,691 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.67 per share. | 02 Feb 2018 | 2,330 | 96,151 (0%) | 0% | 4.7 | 10,872 | Common Stock |
| M. Michelle Berrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2018 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | SVP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2018 | 141,750 | 141,750 | - | - | Stock Option (Right to Buy) | |
| Linda M. Richardson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2018 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2018 | 148,500 | 148,500 | - | - | Stock Option (Right to Buy) | |
| Linda M. Richardson | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 4.47 per share. | 01 Dec 2017 | 19,833 | 60,996 (0%) | 0% | 4.5 | 88,673 | Common Stock |
| Patrick C. Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Ronald C. Renaud | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 6,341 | 6,341 | - | - | Stock Option (Right to Buy) | |
| John M. Leonard | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| James Niedel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.26 per share. | 21 Jun 2017 | 23,474 | 323,947 (0%) | 0% | 4.3 | 99,999 | Common Stock |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2017 | 23,474 | 36,482 | - | - | Stock Option (Right to Buy) | |
| Linda M. Richardson | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.68 per share. | 12 May 2017 | 10,167 | 80,829 (0%) | 0% | 4.7 | 47,577 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.68 per share. | 12 May 2017 | 12,712 | 98,481 (0%) | 0% | 4.7 | 59,464 | Common Stock |
| M. Michelle Berrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 4.10 per share. | 10 Mar 2017 | 4,523 | 366,684 (0%) | 0% | 4.1 | 18,531 | Common Stock |
| Timothy W. Trost | SVP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 4.10 per share. | 10 Mar 2017 | 5,186 | 111,931 (0%) | 0% | 4.1 | 21,247 | Common Stock |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 4.10 per share. | 10 Mar 2017 | 587 | 111,193 (0%) | 0% | 4.1 | 2,405 | Common Stock |
| M. Michelle Berrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2017 | 148,000 | 148,000 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2017 | 74,000 | 362,161 (0%) | 0% | 0 | Common Stock | |
| Timothy W. Trost | SVP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2017 | 25,375 | 106,745 (0%) | 0% | 0 | Common Stock | |
| Timothy W. Trost | SVP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2017 | 50,750 | 50,750 | - | - | Stock Option (Right to Buy) | |
| Linda M. Richardson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2017 | 30,375 | 90,996 (0%) | 0% | 0 | Common Stock | |
| Linda M. Richardson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2017 | 60,750 | 60,750 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2017 | 30,375 | 110,606 (0%) | 0% | 0 | Common Stock | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2017 | 60,750 | 60,750 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Dec 2016 | 72,073 | 296,462 | - | - | Common Stock | |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Dec 2016 | 3,636 | 292,826 | - | - | Common Stock | |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Dec 2016 | 4,000 | 288,826 | - | - | Common Stock | |
| Ernest Mario | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Dec 2016 | 20,291 | 268,535 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2016 | 2,400 | 59,956 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2016 | 2,400 | 288,161 | - | - | Common Stock | |
| John M. Leonard | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 5,000 | 0 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2016 | 4,523 | 285,761 | - | - | Common Stock | |
| Timothy W. Trost | SVP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2016 | 4,638 | 81,370 | - | - | Common Stock | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2016 | 3,566 | 80,231 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Aug 2016 | 22,417 | 281,238 | - | - | Common Stock | |
| Ernest Mario | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2016 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2016 | 9,634 | 9,634 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2016 | 50,000 | 381,440 | - | - | Common Stock | |
| Martha J. Demski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2016 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| C. Patrick Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2016 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Ronald C. Renaud | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2016 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| John M. Leonard | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2016 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2016 | 13,188 | 258,821 | - | - | Common Stock | |
| Lisa Ricciardi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2016 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2016 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| James Niedel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2016 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2016 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 May 2016 | 10,000 | 331,440 | - | - | Common Stock | |
| Ernest Mario | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 May 2016 | 800 | 297,240 | - | - | Common Stock | |
| Ernest Mario | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 May 2016 | 24,200 | 321,440 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2016 | 100,000 | 245,633 | - | - | Common Stock | |
| Timothy W. Trost | SVP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2016 | 60,000 | 76,732 | - | - | Common Stock | |
| Linda M. Richardson | Chief Commerical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2016 | 60,000 | 60,621 | - | - | Common Stock | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2016 | 75,000 | 76,665 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2016 | 1,761 | 15,845 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2016 | 1,761 | 296,440 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2016 | 1,760 | 17,606 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2016 | 1,760 | 294,679 | - | - | Common Stock | |
| Ernest Mario | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Mar 2016 | 20,000 | 287,919 | - | - | Common Stock | |
| Ernest Mario | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Mar 2016 | 5,000 | 292,919 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2016 | 1,761 | 19,366 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2016 | 1,761 | 267,919 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2016 | 11,001 | 62,356 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2016 | 11,001 | 145,633 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2016 | 1,760 | 21,127 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2016 | 1,760 | 266,158 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2016 | 1,761 | 22,887 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2016 | 1,761 | 264,398 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2016 | 483,600 | 483,600 | - | - | Stock Option (Right to Buy) | |
| Michael D. Rogers | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2016 | 178,000 | 178,000 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | SVP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2016 | 178,000 | 178,000 | - | - | Stock Option (Right to Buy) | |
| Linda M. Richardson | Chief Commerical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2016 | 178,000 | 178,000 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2016 | 178,000 | 178,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Dec 2015 | 125,000 | 262,637 | - | - | Common Stock | |
| C. Patrick Machado | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Dec 2015 | 10,000 | 10,000 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2015 | 1,760 | 24,648 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2015 | 1,760 | 137,637 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2015 | 1,761 | 26,408 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2015 | 1,761 | 135,877 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2015 | 1,126 | 0 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2015 | 1,126 | 1,126 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Nov 2015 | 100 | 1,026 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Nov 2015 | 100 | 926 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Nov 2015 | 926 | 0 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2015 | 1,761 | 28,169 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2015 | 1,761 | 134,116 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2015 | 2,000 | 1,126 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2015 | 2,000 | 2,000 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Oct 2015 | 1,800 | 200 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Oct 2015 | 200 | 0 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2015 | 1,760 | 29,930 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2015 | 832 | 8,319 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2015 | 1,760 | 131,523 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2015 | 832 | 132,355 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2015 | 2,000 | 3,126 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2015 | 2,000 | 2,000 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Sep 2015 | 1,562 | 438 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Sep 2015 | 438 | 0 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2015 | 2,796 | 58,713 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2015 | 2,796 | 133,434 | - | - | Common Stock | |
| John M. Leonard | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Aug 2015 | 1,000 | 1,000 | - | - | Common Stock | |
| Timothy W. Trost | SVP, CFO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2015 | 5,333 | 44,734 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | SVP, CFO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2015 | 5,333 | 15,183 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 3,521 | 31,690 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 750 | 0 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 129 | 0 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 832 | 9,151 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 3,521 | 128,052 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 750 | 128,802 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 129 | 128,931 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 832 | 129,763 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2015 | 2,000 | 5,126 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2015 | 2,000 | 2,000 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Aug 2015 | 2,000 | 0 | - | - | Common Stock | |
| Timothy W. Trost | SVP, CFO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2015 | 28,000 | 78,461 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | SVP, CFO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2015 | 28,000 | 37,850 | - | - | Common Stock | |
| Timothy W. Trost | SVP, CFO & Secretary | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Jul 2015 | 28,000 | 9,850 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2015 | 2,000 | 7,126 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2015 | 2,000 | 2,000 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jul 2015 | 1,300 | 700 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jul 2015 | 700 | 0 | - | - | Common Stock | |
| Ernest Mario | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2015 | 9,983 | 9,983 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| C. Patrick Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Ronald C. Renaud | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| John M. Leonard | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Lisa Ricciardi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| James Niedel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2015 | 3,521 | 35,211 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2015 | 1,500 | 750 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2015 | 258 | 129 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2015 | 3,521 | 122,773 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2015 | 1,500 | 124,273 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2015 | 258 | 124,531 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2015 | 2,000 | 9,126 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2015 | 2,000 | 2,000 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2015 | 2,000 | 0 | - | - | Common Stock | |
| Lisa Ricciardi | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 May 2015 | 1,950 | 1,950 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2015 | 2,000 | 11,126 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2015 | 2,000 | 2,000 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 May 2015 | 2,000 | 0 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 1,761 | 38,732 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 750 | 2,250 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 130 | 387 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 1,761 | 118,372 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 750 | 119,122 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 130 | 119,252 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2015 | 2,000 | 13,126 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2015 | 2,000 | 2,000 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Apr 2015 | 1,700 | 300 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Apr 2015 | 300 | 0 | - | - | Common Stock | |
| Michael D. Rogers | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2015 | 6,372 | 79,219 | - | - | Stock Option (Right to Buy) | |
| Michael D. Rogers | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2015 | 6,372 | 21,630 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2015 | 7,335 | 73,357 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2015 | 5,591 | 61,509 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2015 | 7,335 | 125,047 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2015 | 5,591 | 130,638 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 3,521 | 40,493 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 1,500 | 3,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 258 | 517 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 3,521 | 114,853 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 1,500 | 116,353 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 258 | 116,611 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2015 | 2,000 | 15,126 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2015 | 2,000 | 2,000 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Mar 2015 | 1,500 | 500 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Mar 2015 | 500 | 0 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2015 | 2,000 | 17,126 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2015 | 2,000 | 2,000 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Feb 2015 | 2,000 | 0 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2015 | 184,200 | 184,200 | - | - | Stock Option (Right to Buy) | |
| Michael D. Rogers | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2015 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | Sr. Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2015 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Linda M. Richardson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2015 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2015 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2015 | 3,668 | 80,692 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2015 | 3,668 | 116,282 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2015 | 3,521 | 44,014 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2015 | 1,500 | 4,500 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2015 | 258 | 775 | - | - | Common Stock (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2015 | 3,521 | 109,574 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2015 | 1,500 | 111,074 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2015 | 258 | 111,332 | - | - | Common Stock | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2015 | 2,000 | 19,126 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2015 | 2,000 | 2,000 | - | - | Common Stock | |
| Martha J. Demski | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 2,000 | 0 | - | - | Common Stock | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2014 | 14,672 | 84,360 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2014 | 14,672 | 112,614 | - | - | Common Stock | |
| Ronald C. Renaud | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2014 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | Sr. Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2014 | 5,333 | 50,067 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | Sr. Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2014 | 5,333 | 9,172 | - | - | Common Stock | |
| John M. Leonard | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Nov 2014 | 4,000 | 4,000 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2014 | 5,282 | 47,535 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2014 | 3,000 | 6,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2014 | 517 | 1,033 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2014 | 5,282 | 92,536 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2014 | 3,000 | 95,536 | - | - | Common Stock | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2014 | 517 | 96,053 | - | - | Common Stock | |
| Ernest Mario | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Nov 2014 | 10,000 | 106,053 | - | - | Common Stock | |
| Timothy W. Trost | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Oct 2014 | 10,000 | 10,000 | - | - | Common Stock | |
| Timothy W. Trost | None | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Oct 2014 | 57 | 101 | - | - | Commnon Stock | |
| Timothy W. Trost | None | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Oct 2014 | 101 | 0 | - | - | Common Stock | |
| Timothy W. Trost | None | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Oct 2014 | 101 | 8,702 | - | - | Common Stock | |
| Timothy W. Trost | Sr. Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2014 | 5,000 | 8,839 | - | - | Common Stock | |
| Timothy W. Trost | Sr. Vice President and CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Sep 2014 | 5,000 | 3,839 | - | - | Common Stock | |
| Timothy W. Trost | Sr. Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2014 | 5,000 | 109,014 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Sep 2014 | 164,600 | 3,766,100 | - | - | Common Stock | |
| Timothy W. Trost | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Sep 2014 | 40,300 | 3,725,800 | - | - | Common Stock | |
| Timothy W. Trost | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Sep 2014 | 81,200 | 3,644,600 | - | - | Common Stock | |
| Timothy W. Trost | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Sep 2014 | 133,900 | 3,510,700 | - | - | Common Stock | |
| Timothy W. Trost | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Sep 2014 | 199,300 | 3,311,400 | - | - | Common Stock | |
| Timothy W. Trost | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Sep 2014 | 158 | 8,891 | - | - | Common Stock | |
| Timothy W. Trost | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Sep 2014 | 8,733 | 158 | - | - | Common Stock | |
| Timothy W. Trost | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Sep 2014 | 8,601 | 8,601 | - | - | Common Stock | |
| Timothy W. Trost | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Sep 2014 | 122,950 | 3,930,700 | - | - | Common Stock | |
| James Niedel | None | 09 Sep 2014 | 200,879 | 401,758 | - | - | Warrant | ||
| James Niedel | None | 09 Sep 2014 | 401,758 | 0 | - | - | Warrant | ||
| James Niedel | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Sep 2014 | 217,321 | 1,326,073 | - | - | Common Stock | |
| James Niedel | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Sep 2014 | 58,531 | 1,267,542 | - | - | Common Stock | |
| James Niedel | None | 09 Sep 2014 | 200,879 | 1,468,421 | - | - | Common Stock | ||
| James Niedel | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Sep 2014 | 51,100 | 1,417,321 | - | - | Common Stock | |
| James Niedel | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Sep 2014 | 347,188 | 1,070,133 | - | - | Common Stock | |
| James Niedel | None | 09 Sep 2014 | 401,758 | 1,471,891 | - | - | Common Stock | ||
| James Niedel | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Sep 2014 | 97,129 | 1,374,762 | - | - | Common Stock | |
| James Niedel | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Sep 2014 | 328,680 | 1,046,082 | - | - | Common Stock | |
| Ernest Mario | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Sep 2014 | 10,000 | 87,254 | - | - | Common Stock | |
| Timothy W. Trost | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Sep 2014 | 7,735 | 4,145,915 | - | - | Common Stock | |
| Timothy W. Trost | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Sep 2014 | 92,265 | 4,053,650 | - | - | Common Stock | |
| M. Michelle Berrey | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2014 | 14,671 | 99,032 | - | - | Stock Option (Right to Buy) | |
| M. Michelle Berrey | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2014 | 14,671 | 97,942 | - | - | Common Stock | |
| William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2014 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2014 | 8,803 | 52,817 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2014 | 8,803 | 77,254 | - | - | Common Stock | |
| Timothy W. Trost | Sr. Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2014 | 5,000 | 8,182 | - | - | Common Stock | |
| Timothy W. Trost | Sr. Vice President and CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Aug 2014 | 5,000 | 3,182 | - | - | Common Stock | |
| Timothy W. Trost | Sr. Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2014 | 5,000 | 114,014 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | SVP, CFO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2014 | 5,000 | 111,461 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2014 | 5,000 | 119,014 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2014 | 2,553 | 116,461 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2014 | 5,000 | 5,629 | - | - | Common Stock | |
| Timothy W. Trost | See Remarks | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Jul 2014 | 5,000 | 629 | - | - | Common Stock | |
| Timothy W. Trost | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2014 | 2,553 | 3,182 | - | - | Common Stock | |
| Timothy W. Trost | Sr. Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2014 | 5,000 | 124,014 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | Sr. Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2014 | 5,000 | 5,629 | - | - | Common Stock | |
| Timothy W. Trost | Sr. Vice President and CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Jun 2014 | 5,000 | 629 | - | - | Common Stock | |
| Ernest Mario | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 1,550 | 1,550 | - | - | Stock Option (Right to Buy) | |
| Rodman L. Drake | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Martha J. Demski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| C. Patrick Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| C. Patrick Machado | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| John M. Leonard | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| John M. Leonard | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Lisa Ricciardi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| James Niedel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Catherine L. Gilliss | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2014 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Ernest Mario | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 May 2014 | 10,000 | 68,451 | - | - | Common Stock | |
| M. Michelle Berrey | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 May 2014 | 14,065 | 83,271 | - | - | Common Stock | |
| Timothy W. Trost | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2014 | 5,000 | 129,014 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2014 | 5,000 | 5,629 | - | - | Common Stock | |
| Timothy W. Trost | SVP and CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 May 2014 | 5,000 | 629 | - | - | Common Stock | |
| M. Michelle Berrey | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2014 | 18,339 | 69,206 | - | - | Common Stock | |
| M. Michelle Berrey | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2014 | 18,339 | 113,703 | - | - | Stock Option (Right to Buy) | |
| Michael D. Rogers | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2014 | 13,000 | 85,591 | - | - | Stock Option (Right to Buy) | |
| Michael D. Rogers | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2014 | 13,000 | 13,870 | - | - | Common Stock | |
| Timothy W. Trost | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2014 | 5,000 | 134,014 | - | - | Stock Option (Right to Buy) | |
| Timothy W. Trost | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2014 | 5,000 | 5,629 | - | - | Common Stock |